Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes Zoster [NA]

View source ↗

Summary

Clinical trial update indicates Crisugabalin is being studied for analgesic efficacy and safety in patients with herpes zoster; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Crisugabalin (crisugabalin)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Herpes Zoster, Pain | NA | Status: RECRUITING